Kevin Huang
Psychiatry · Phila, PANPI 1831378975
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 297 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 297 payments — averaging $46.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- Neurocrine Biosciences, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$842
- plus $3K from 10 others
What the payments were for
- Food & beverage$13,44398%
- Education$2212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 59 | $2,545 |
| Teva Pharmaceuticals USA, Inc. | 44 | $2,301 |
| Otsuka America Pharmaceutical, Inc. | 21 | $1,713 |
| AbbVie(2 entities) | 35 | $1,532 |
| Neurocrine Biosciences, Inc. | 38 | $1,376 |
| E.r. Squibb & Sons, L.L.C. | 16 | $842 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $823 |
| Sunovion Pharmaceuticals Inc. | 29 | $762 |
| Alkermes, Inc. | 19 | $689 |
| Janssen Scientific Affairs, LLC | 5 | $543 |
| Lundbeck LLC | 10 | $193 |
| Acadia Pharmaceuticals Inc | 2 | $125 |
| Corium, LLC | 1 | $122 |
| Avanir Pharmaceuticals, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$1,121
- VRAYLAR$1,057
- ARISTADA$999
- REXULTI$957
- INGREZZA$724
- CAPLYTA$694
- ABILIFY MAINTENA$618
- COBENFY$473
- LYBALVI$458
- Austedo XR$443
- UZEDY$431
- AUSTEDO$385
- ABILIFY ASIMTUFII$370
- ARISTADA INITIO$250
- LATUDA$241
- Azstarys$122
- SPRAVATO$120
- INVEGA TRINZA$115
How this compares
$13,664 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 18 | $664 |
| Olanzapine | 53 | $572 |
| Bupropion XlBupropion Hcl | 17 | $272 |
| Trazodone Hcl | 37 | $220 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $212 |
| Quetiapine Fumarate | 23 | $205 |
| Benztropine Mesylate | 21 | $164 |
| Sertraline Hcl | 24 | $137 |
| Divalproex Sodium | 12 | $130 |
| Risperidone | 27 | $125 |
| Escitalopram Oxalate | 11 | $78 |
| Fluoxetine Hcl | 19 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Phila
- Rebecca RomaPittsburgh$3.3M
- Robert NelsonWyomissing$2.2M
- Matthew BergerMoosic$1.7M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
- Daniel WeintraubPhiladelphia$647K
- Sachin MehtaBlue Bell$646K
- Jane JesseKingston$617K
- Michael ThasePhiladelphia$396K
- Michael KwiatBeaver$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.